Understand the source comparison
LIPO-C Dosage B12 2026: Formulation Comparison
Conservative Standard 500mg 50mg 100mg 1000mcg Weekly 12–16% hepatic fat reduction over 12 weeks (Nutrients 2025 review) Proven baseline efficacy but may leave enzymatic capacity underutilised. B12 is often the bottleneck High-Saturation Protocol 5000mcg 22–28
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Conservative Standard
- 500mg
- 50mg
- 100mg
- 1000mcg
- Weekly
- 12–16% hepatic fat reduction over 12 weeks (Nutrients 2025 review)
- Proven baseline efficacy but may leave enzymatic capacity underutilised. B12 is often the bottleneck
- High-Saturation Protocol
- 5000mcg
- 22–28% hepatic fat reduction over 12 weeks (Nutrients 2025 review)
- Currently the research-supported optimum. Saturates methionine synthase fully and eliminates B12 as rate-limiting factor
- Carnitine-Heavy Protocol
- 750mg
- Marginal improvement over 500mg L-carnitine. Increased renal clearance without proportional benefit
- Exceeds CPT1 saturation threshold without addressing methyl-donor pathway limitations
- Lipotropic-Only Protocol
- 0mg
- 200mg
- Limited fat mobilisation without carnitine-mediated mitochondrial transport
- Supports methyl-donor cycle but lacks the fatty acid shuttle mechanism L-carnitine provides
- The High-Saturation Protocol represents the current research consensus for best LIPO-C dosage B12 2026. It balances all four components at concentrations where enzymatic pathways operate at maximum efficiency without exceeding hepatic or renal clearance capacity.